البحث | Friends - Best Social Network - החברים

Devidi Jahnavi أضاف وظيفة جديدة Health
2025-07-07 09:07:47

2025 Cystic Fibrosis Pipeline: Key Clinical Trials and Biotech Advancements
What is the projected growth rate (CAGR) of the Global Vascular Endothelial Growth Factor Receptor Inhibitors Market from 2024 to 2031, and what is the market value expected to change by 2031? Global Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market reached US$14.12 billion in 2024 and is expected to reach US$22.34 billion by 2033, growing at a CAGR of 5.9 % during the...

0 التعليقات 0 المشاركات 571 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Devidi Jahnavi أضاف وظيفة جديدة Health
2025-07-07 07:05:23

Cystic Fibrosis *** Development Pipeline 2025: Gene Therapy and CFTR Modulators
What is the projected growth rate (CAGR) of the Cystic Fibrosis Pipeline Insights 2025, and what is the market value expected to change by 2033? The Cystic Fibrosis Market is projected to reach a significant value by 2033, growing at a promising CAGR during the forecast period. What is Cystic Fibrosis Pipeline Insights 2025? Cystic fibrosis (CF) is a rare, inherited genetic disorder that...

0 التعليقات 0 المشاركات 634 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Devidi Jahnavi أضاف وظيفة جديدة Health
2025-06-18 05:08:46

Emerging Biomarkers in Idiopathic Pulmonary Fibrosis Management
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease defined by irreversible scarring of lung tissue. While it has long presented challenges due to late diagnosis and limited treatment options, recent clinical advances and heightened awareness are shifting the treatment paradigm. As novel antifibrotic therapies evolve and precision approaches become integrated...

0 التعليقات 0 المشاركات 793 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Kan Kumar أضاف وظيفة جديدة Health
2025-07-10 09:01:28

Non-Cystic Fibrosis Bronchiectasis Market Forecast to 2034: Key Insights by DelveInsight
The Non-Cystic Fibrosis Bronchiectasis Market is experiencing unprecedented growth as healthcare stakeholders recognize this underdiagnosed chronic respiratory condition's significant impact. Non-Cystic Fibrosis Bronchiectasis (NCFB) presents with irreversible bronchial dilation, persistent cough, sputum production, and recurring respiratory infections. Distinguished from cystic...

0 التعليقات 0 المشاركات 595 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Uttej Netha أضاف وظيفة جديدة Health
2025-06-30 10:41:33

U.S. Dominates Global MASH Therapy Landscape with 43% Market Share
The North America Metabolic Dysfunction–Associated Steatohepatitis (MASH) Treatment Market is witnessing exponential growth, rising from USD 3.70 billion in 2024 to an anticipated USD 17.15 billion by 2033, at a strong compound annual growth rate (CAGR) of 19.3% from 2025 to 2033. This dynamic expansion is fueled by the increasing prevalence of obesity, Type 2 diabetes, aging population,...

0 التعليقات 0 المشاركات 847 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!